Isoliquiritigenin selectively inhibits H2 histamine receptor signaling

被引:31
作者
Kim, Dong-Chan
Choi, Se-Young
Kim, Sun-Hee
Yun, Bong-Sik
Yoo, Ick-Dong
Reddy, Nanga. Ravi Prakash
Yoon, Ho Sup
Kim, Kyong-Tai
机构
[1] POSTECH, Dept Life Sci, Div Mol & Life Sci, Syst Biodynam Natl Core Res Ctr, Pohang 790784, South Korea
[2] Neuronex Inc, Div Res & Dev, Pohang, South Korea
[3] Seoul Natl Univ, Coll Dent, Dept Physiol, Seoul, South Korea
[4] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea
[5] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore
关键词
D O I
10.1124/mol.106.023226
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Isoliquiritigenin, one of the major constituents of Glycyrrhiza uralensis (licorice), is a natural pigment with a simple chalcone structure 4,2',4'-trihydroxychalcone. In this study, isoliquiritigenin showed selective H 2 histamine receptor ( H 2 R) antagonistic effect and remarkably reduced several H2R-mediated physiological responses. Preincubation of U937 and HL60 hematopoietic cells with isoliquiritigenin significantly inhibited H2R agonist-induced cAMP response in a concentration-dependent manner without affecting the viability of cells. Isoliquiritigenin also blocked the binding affinity of [H-3] tiotidine to membrane receptors in HL-60 cells. Isoliquiritigenin did not affect the elevation of cAMP levels induced by cholera toxin, forskolin, or isoproterenol, indicating that the action site of isoliquiritigenin is not G(s) protein, effector enzyme, adenylyl cyclase, or beta 2-adrenoceptor. Isoliquiritigenin affected neither H1R- nor H3R-mediated signaling. In molecular docking studies, isoliquiritigenin exhibited more favorable interactions with H2R than histamine. Isoliquiritigenin prominently inhibited H2R selective agonist dimaprit-induced cAMP generation in MKN-45 gastric cancer cell. Moreover, isoliquiritigenin reduced gastric acid secretion and protected gastric mucosal lesion formation in pylorus-ligated rat model. Taken together, the results demonstrate that isoliquiritigenin is an effective H2R antagonist and provides the basis for designing novel H2R antagonist.
引用
收藏
页码:493 / 500
页数:8
相关论文
共 29 条
[1]  
Alewijnse AE, 1998, J NEUROCHEM, V71, P799
[2]   PRESENCE OF HISTAMINE-H2-RECEPTORS ON HUMAN GASTRIC-CARCINOMA CELL-LINE MKN-45 AND THEIR INCREASE BY RETINOIC ACID TREATMENT [J].
ARIMA, N ;
YAMASHITA, Y ;
NAKATA, H ;
NAKAMURA, A ;
KINOSHITA, Y ;
CHIBA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (03) :1027-1032
[3]   Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis [J].
Baba, M ;
Asano, R ;
Takigami, I ;
Takahashi, T ;
Ohmura, M ;
Okada, Y ;
Sugimoto, H ;
Arika, T ;
Nishino, H ;
Okuyama, T .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (02) :247-250
[4]  
Bakker Remko A, 2002, Clin Allergy Immunol, V17, P27
[5]   DEFINITION AND ANTAGONISM OF HISTAMINE H2-RECEPTORS [J].
BLACK, JW ;
PARSONS, EM ;
DURANT, CJ ;
DUNCAN, WAM ;
GANELLIN, CR .
NATURE, 1972, 236 (5347) :385-&
[6]   Modeling of loops in protein structures [J].
Fiser, A ;
Do, RKG ;
Sali, A .
PROTEIN SCIENCE, 2000, 9 (09) :1753-1773
[7]   Anti-Helicobacter pylori flavonoids from licorice extract [J].
Fukai, T ;
Marumo, A ;
Kaitou, K ;
Kanda, T ;
Terada, S ;
Nomura, T .
LIFE SCIENCES, 2002, 71 (12) :1449-1463
[8]   MOLECULAR-CLONING OF A GENE ENCODING THE HISTAMINE-H2-RECEPTOR [J].
GANTZ, I ;
SCHAFFER, M ;
DELVALLE, J ;
LOGSDON, C ;
CAMPBELL, V ;
UHLER, M ;
YAMADA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :429-433
[9]   Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells [J].
Gutzmer, R ;
Diestel, C ;
Mommert, S ;
Köther, B ;
Stark, H ;
Wittmann, M ;
Werfel, T .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5224-5232
[10]   Histamine in allergic inflammation and immune modulation [J].
Jutel, M ;
Blaser, K ;
Akdis, CA .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 137 (01) :82-92